Selskabsmeddelelse8.8.2025, 13.30The Swedish Companies Registration Office has granted permission to implement the merger plan between Flerie and Toleranzia
Selskabsmeddelelse25.6.2025, 16.10Toleranzia applies for delisting of the Company’s shares from Nasdaq First North Growth Market, conditional upon completion of the merger with Flerie
Selskabsmeddelelse5.6.2025, 10.20Announcement from the 2025 Annual General Meeting of Toleranzia AB (publ)
Selskabsmeddelelse25.3.2025, 09.32Statement by the Board of Directors of Toleranzia in view of the merger offer by Flerie
Selskabsmeddelelse25.3.2025, 09.30Flerie and Toleranzia have agreed on a merger plan to take Toleranzia private
Pressemeddelelse11.3.2025, 08.55Toleranzia seeks a scientific advice meeting with the Danish Medicines Agency
Selskabsmeddelelse20.2.2025, 14.57Toleranzia’s clinical trial application (CTA) for TOL2 approved in Germany while declined in Denmark